{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:43:18Z","timestamp":1792478598786,"version":"4.5.0"},"reference-count":64,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15866","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:59:57Z","timestamp":1789469997000},"page":"1-11","source":"Crossref","is-referenced-by-count":0,"title":["Role of tumor necrosis factor receptor superfamily member 19 in cancer: Diverse functions and therapeutic potential (Review)"],"prefix":"10.3892","volume":"32","author":[{"given":"Manyu","family":"Xu","sequence":"first","affiliation":[{"name":"College of Basic Medical Sciences, Jiamusi University, Jiamusi, Heilongjiang 154007, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Jiamusi University, Jiamusi, Heilongjiang 154007, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, School of Medicine, Taizhou University, Taizhou, Zhejiang 318000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyun","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, School of Medicine, Taizhou University, Taizhou, Zhejiang 318000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, School of Medicine, Taizhou University, Taizhou, Zhejiang 318000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Jiamusi University, Jiamusi, Heilongjiang 154007, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong-Ying","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, School of Medicine, Taizhou University, Taizhou, Zhejiang 318000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Jiamusi University, Jiamusi, Heilongjiang 154007, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"key20261020093229_b1-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"13964","DOI":"10.1074\/jbc.M601553200","article-title":"Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human","volume":"281","author":"Bossen","year":"2006","journal-title":"J Biol Chem"},{"key":"key20261020093229_b2-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: A double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"key20261020093229_b3-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0968-0004(01)01995-8","article-title":"The molecular architecture of the TNF superfamily","volume":"27","author":"Bodmer","year":"2002","journal-title":"Trends Biochem Sci"},{"key":"key20261020093229_b4-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13046-022-02401-6","article-title":"Targeting TROY-mediated P85a\/AKT\/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma","volume":"41","author":"Liu","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"key20261020093229_b5-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"e28445","DOI":"10.1016\/j.heliyon.2024.e28445","article-title":"Association of TNFRSF19 with a TNF family-based prognostic model and subtypes in gliomas using machine learning","volume":"10","author":"Guo","year":"2024","journal-title":"Heliyon"},{"key":"key20261020093229_b6-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1158\/0008-5472.CAN-17-3205","article-title":"TNFRSF19 Inhibits TGF\u03b2 signaling through interaction with TGF\u03b2 receptor type I to promote Tumorigenesis","volume":"78","author":"Deng","journal-title":"Cancer Res"},{"key":"key20261020093229_b7-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41417-023-00696-x","article-title":"TNFRSF19 promotes endoplasmic reticulum stress-induced paraptosis via the activation of the MAPK pathway in triple-negative breast cancer cells","volume":"31","author":"Liu","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"key20261020093229_b8-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"50557","DOI":"10.18632\/oncotarget.10672","article-title":"Troy is expressed in human stomach mucosa and a novel putative prognostic marker of intestinal type gastric cancer","volume":"8","author":"Wilhelm","year":"2017","journal-title":"Oncotarget"},{"key":"key20261020093229_b9-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jhep.2022.03.015","article-title":"Unique molecular characteristics of NAFLD-associated liver cancer accentuate \u03b2-catenin\/TNFRSF19-mediated immune evasion","volume":"77","author":"Wong","year":"2022","journal-title":"J Hepatol"},{"key":"key20261020093229_b10-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1158\/1541-7786.MCR-13-0008","article-title":"TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance","volume":"11","author":"Loftus","year":"2013","journal-title":"Mol Cancer Res"},{"key":"key20261020093229_b11-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"881875","DOI":"10.3389\/fgene.2022.881875","article-title":"TROY modulates cancer Stem-Like cell properties and gefitinib resistance through EMT signaling in Non-small cell lung cancer","volume":"13","author":"Wu","year":"2022","journal-title":"Front Genet"},{"key":"key20261020093229_b12-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0165-3806(03)00101-9","article-title":"Expression of a member of tumor necrosis factor receptor superfamily, TROY, in the developing mouse brain","volume":"143","author":"Hisaoka","year":"2003","journal-title":"Brain Res Dev Brain Res"},{"key":"key20261020093229_b13-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"15336","DOI":"10.1074\/jbc.275.20.15336","article-title":"TAJ, a novel member of the tumor necrosis factor receptor family, activates the c-Jun N-terminal kinase pathway and mediates Caspase-independent cell death","volume":"275","author":"Eby","year":"2000","journal-title":"J Biol Chem"},{"key":"key20261020093229_b14-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/embor.2011.175","article-title":"LGR4 and LGR5 are R-spondin receptors mediating Wnt\/\u03b2-catenin and Wnt\/PCP signalling","volume":"12","author":"Glinka","year":"2011","journal-title":"EMBO Rep"},{"key":"key20261020093229_b15-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature10337","article-title":"Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling","volume":"476","author":"de Lau","year":"2011","journal-title":"Nature"},{"key":"key20261020093229_b16-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature09637","article-title":"Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts","volume":"469","author":"Sato","year":"2011","journal-title":"Nature"},{"key":"key20261020093229_b17-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1053\/j.gastro.2012.10.048","article-title":"Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem cells","volume":"144","author":"Fafilek","year":"2013","journal-title":"Gastroenterology"},{"key":"key20261020093229_b18-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.mcn.2006.12.004","article-title":"Expression profile of receptors for myelin-associated inhibitors of axonal regeneration in the intact and injured mouse central nervous system","volume":"34","author":"Barrette","year":"2007","journal-title":"Mol Cell Neurosci"},{"key":"key20261020093229_b19-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"20742","DOI":"10.1074\/jbc.M002691200","article-title":"TROY, a newly identified member of the tumor necrosis factor receptor superfamily, exhibits a homology with Edar and is expressed in embryonic skin and hair follicles","volume":"275","author":"Kojima","year":"2000","journal-title":"J Biol Chem"},{"key":"key20261020093229_b20-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"34276","DOI":"10.1074\/jbc.M113.519744","article-title":"TROY interacts with rho guanine nucleotide dissociation inhibitor \u03b1 (RhoGDI\u03b1) to mediate Nogo-induced inhibition of neurite outgrowth","volume":"288","author":"Lu","year":"2013","journal-title":"J Biol Chem"},{"key":"key20261020093229_b21-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/cbin.70021","article-title":"Distribution of troy (Tnfrsf19) in the gastric gland during postnatal development: Effects of early weaning","volume":"49","author":"Rattes","year":"2025","journal-title":"Cell Biol Int"},{"key":"key20261020093229_b22-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.neuron.2004.12.050","article-title":"TAJ\/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration","volume":"45","author":"Shao","year":"2005","journal-title":"Neuron"},{"key":"key20261020093229_b23-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"14438","DOI":"10.1074\/jbc.M109.052001","article-title":"Tumor necrosis factor receptor superfamily member 19 (TNFRSF19) regulates differentiation fate of human mesenchymal (Stromal) stem cells through canonical wnt signaling and C\/EBP","volume":"285","author":"Qiu","year":"2010","journal-title":"J Biol Chem"},{"key":"key20261020093229_b24-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/ijc.28839","article-title":"\u03b2-catenin regulates NF-\u03baB activity via TNFRSF19 in colorectal cancer cells","volume":"135","author":"Sch\u00f6n","year":"2014","journal-title":"Int J Cancer"},{"key":"key20261020093229_b25-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.neo.2018.08.008","article-title":"PDZ-RhoGEF is a signaling effector for TROY-induced glioblastoma cell invasion and survival","volume":"20","author":"Ding","year":"2018","journal-title":"Neoplasia"},{"key":"key20261020093229_b26-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neuron.2004.12.040","article-title":"A TNF receptor family member, TROY, is a Coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors","volume":"45","author":"Park","year":"2005","journal-title":"Neuron"},{"key":"key20261020093229_b27-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"106083","DOI":"10.1016\/j.bbi.2025.106083","article-title":"Breakdown of blood-brain barrier, astrocytic endfeet swelling, and abnormal behaviors by blockade of TROY signaling in TROY-Fc transgenic mice","volume":"130","author":"Komori","year":"2025","journal-title":"Brain Behav Immun"},{"key":"key20261020093229_b28-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1042\/bj3350465","article-title":"Signal transduction of stress via ceramide","volume":"335","author":"Mathias","year":"1998","journal-title":"Biochem J"},{"key":"key20261020093229_b29-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"22681","DOI":"10.1074\/jbc.273.35.22681","article-title":"Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)\/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase\/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38","volume":"273","author":"Yuasa","year":"1998","journal-title":"Biol Chem"},{"key":"key20261020093229_b30-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.devcel.2024.03.011","article-title":"Defining the contribution of Troy-positive progenitor cells to the mouse esophageal epithelium)","volume":"59","author":"Grommisch","year":"2024","journal-title":"Dev Cell"},{"key":"key20261020093229_b31-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1093\/hmg\/ddn232","article-title":"Edar and Troy signalling pathways act redundantly to regulate initiation of hair follicle development","volume":"17","author":"Pispa","year":"2008","journal-title":"Hum Mol Genet"},{"key":"key20261020093229_b32-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/dvdy.10400","article-title":"Traf6 is essential for murine tooth cusp morphogenesis","volume":"229","author":"Ohazama","year":"2004","journal-title":"Dev Dyn"},{"key":"key20261020093229_b33-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.cell.2013.09.008","article-title":"Differentiated Troy+ chief cells act as reserve stem cells to generate all lineages of the stomach epithelium","volume":"155","author":"Stange","year":"2013","journal-title":"Cell"},{"key":"key20261020093229_b34-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"100308","DOI":"10.1016\/j.slast.2025.100308","article-title":"CircTNFRSF19 facilitates triple negative breast cancer cell growth by regulating N6-methyladenosine modification of B3GNT5: Medical biological image simulation","volume":"33","author":"Xue","year":"2025","journal-title":"SLAS Technology"},{"key":"key20261020093229_b35-ol-32-5-15866","first-page":"141","article-title":"Update in global trends and aetiology of hepatocellular carcinoma","volume":"22","author":"Rawla","year":"2018","journal-title":"Contemp Oncol (Pozn)"},{"key":"key20261020093229_b36-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bbrc.2020.02.105","article-title":"Downregulation of TNFRSF19 and RAB43 by a novel miRNA, miR-HCC3, promotes proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma cells","volume":"525","author":"Guo","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"key20261020093229_b37-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41431-025-01992-w","article-title":"Hereditary diffuse gastric cancer in progress: Comparative lessons from Lynch syndrome","volume":"34","author":"Pereira","year":"2026","journal-title":"Eur J Hum Genet"},{"key":"key20261020093229_b38-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"6439975","DOI":"10.1155\/2021\/6439975","article-title":"Development and validation of a TNF Family-based signature for predicting prognosis, tumor immune characteristics, and immunotherapy response in colorectal cancer patients","volume":"2021","author":"Xiao","year":"2021","journal-title":"J Immunol Res"},{"key":"key20261020093229_b39-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1053\/j.gastro.2012.10.048","article-title":"Troy, a tumor necrosis factor receptor family member, interacts with Lgr5 to inhibit wnt signaling in intestinal stem cells","volume":"144","author":"Fafilek","year":"2013","journal-title":"Gastroenterology"},{"key":"key20261020093229_b40-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1158\/1541-7786.MCR-17-0454","article-title":"A novel signaling complex between TROY and EGFR mediates glioblastoma cell invasion","volume":"16","author":"Ding","year":"2018","journal-title":"Mol Cancer Res"},{"key":"key20261020093229_b41-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41388-018-0503-x","article-title":"TROY interacts with RKIP to promote glioma development","volume":"38","author":"Liu","year":"2019","journal-title":"Oncogene"},{"key":"key20261020093229_b42-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.neo.2020.06.005","article-title":"TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistance","volume":"22","author":"Ding","year":"2020","journal-title":"Neoplasia"},{"key":"key20261020093229_b43-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s11060-015-1981-0","article-title":"Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway","volume":"126","author":"Dhruv","year":"2016","journal-title":"J Neurooncol"},{"key":"key20261020093229_b44-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"e37955","DOI":"10.1371\/journal.pone.0037955","article-title":"Propentofylline targets TROY, a novel microglial signaling pathway","volume":"7","author":"Jacobs","year":"2012","journal-title":"PLoS One"},{"key":"key20261020093229_b45-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1034\/j.1600-0560.2002.290602.x","article-title":"New prognostic factors of cutaneous melanoma: A review of the literature","volume":"29","author":"Li","year":"2002","journal-title":"J Cutan Pathol"},{"key":"key20261020093229_b46-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","article-title":"The 2018 World Health Organization classification of cutaneous, mucosal, and Uveal melanoma: Detailed analysis of 9 distinct subtypes defined by their evolutionary pathway","volume":"144","author":"Elder","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"key20261020093229_b47-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3233\/CBM-181911","article-title":"TROY expression is associated with pathological stage and poor prognosis in patients treated with radical cystectomy","volume":"24","author":"Nomura","year":"2019","journal-title":"Cancer Biomark"},{"key":"key20261020093229_b48-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/ijc.22367","article-title":"Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target","volume":"120","author":"Spanjaard","year":"2007","journal-title":"Int J Cancer"},{"key":"key20261020093229_b49-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2174\/13894501MTExCNTkBy","article-title":"Colorectal cancer epidemiology: Recent trends and impact on outcomes","volume":"22","author":"Baidoun","year":"2021","journal-title":"Curr Drug Targets"},{"key":"key20261020093229_b50-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.suc.2023.11.009","article-title":"Screening for colorectal cancer","volume":"104","author":"Jacobsson","year":"2024","journal-title":"Surg Clin North Am"},{"key":"key20261020093229_b51-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"e24091","DOI":"10.1016\/j.heliyon.2024.e24091","article-title":"ANKRD2 expression combined with TNFRSF19 expression for evaluating the prognosis of oral squamous cell carcinoma patients","volume":"10","author":"Yao","year":"2024","journal-title":"Heliyon"},{"key":"key20261020093229_b52-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.oraloncology.2019.02.001","article-title":"Survival outcomes after treatment of cancer of the oral cavity (1985\u20132015)","volume":"90","author":"Zanoni","year":"2019","journal-title":"Oral Oncol"},{"key":"key20261020093229_b53-ol-32-5-15866","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20261020093229_b54-ol-32-5-15866","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"key20261020093229_b55-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","article-title":"Non-small-cell lung cancers: A heterogeneous set of diseases","volume":"14","author":"Chen","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"key20261020093229_b56-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13059-019-1696-1","article-title":"The inherited variations of a p53-responsive enhancer in 13q12.12 confer lung cancer risk by attenuating TNFRSF19 expression","volume":"20","author":"Shao","year":"2019","journal-title":"Genome Biol"},{"key":"key20261020093229_b57-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5493\/wjem.v5.i2.84","article-title":"Role of the Wnt\/\u03b2-catenin pathway in gastric cancer: An in-depth literature review","volume":"5","author":"Chiurillo","year":"2015","journal-title":"World J Exp Med"},{"key":"key20261020093229_b58-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"8154926","DOI":"10.1155\/2019\/8154926","article-title":"Research article expression of LGR5, FZD7, TROY, and MIST1 in perioperatively treated gastric carcinomas and correlation with therapy response","volume":"2019","author":"Freiin Grote","year":"2019","journal-title":"Dis Markers"},{"key":"key20261020093229_b59-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"107","DOI":"10.29252\/ibj.23.2.107","article-title":"Immunohistochemical analysis of LGR5 and TROY expression in gastric carcinogenesis demonstrates an inverse trend","volume":"23","author":"Saberi","year":"2019","journal-title":"Iran Biomed J"},{"key":"key20261020093229_b60-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.dld.2022.02.011","article-title":"Long noncoding RNA SNHG8 promotes chemoresistance in gastric cancer via binding with hnRNPA1 and stabilizing TROY expression","volume":"54","author":"Zhu","year":"2022","journal-title":"Dig Liver Dis"},{"key":"key20261020093229_b61-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes-dealing with the diversity of breast cancer: Highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann Oncol"},{"key":"key20261020093229_b62-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res"},{"key":"key20261020093229_b63-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.3390\/cancers14164055","article-title":"TNF receptor associated factor 2 (TRAF2) signaling in cancer","volume":"14","author":"Siegmund","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20261020093229_b64-ol-32-5-15866","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:32:39Z","timestamp":1792477959000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":64,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,15]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15866","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}